Host immune response to infection and cancer: Unexpected commonalities

Cell Host and Microbe

Volumn 15, Issue 3, 2014, Pages 295-305

  Goldszmid, Romina S ^a   Dzutsev, Amiran ^a,b   Trinchieri, Giorgio ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADAPTIVE IMMUNITY; BONE MARROW CELL; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; INFLAMMATION; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MICROFLORA; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TISSUE INJURY; TUMOR GROWTH; TUMOR IMMUNITY;

ADAPTIVE IMMUNITY; COMMUNICABLE DISEASES; IMMUNITY, INNATE; NEOPLASMS;

EID: 84896098517     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2014.02.003     Document Type: Review

References (101)

1. Abt, M.C., Osborne, L.C., Monticelli, L.A., Doering, T.A., Alenghat, T., Sonnenberg, G.F., Paley, M.A., Antenus, M., Williams, K.L., Erikson, J., et al. (2012). Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37, 158-170.
2. Anderson, A.C. (2012). Tim-3, a negative regulator of anti-tumor immunity. Curr. Opin. Immunol. 24, 213-216.
3. Ascensao, J.L., Oken, M.M., Ewing, S.L., Goldberg, R.J., and Kaplan, M.E. (1987). Leukocytosis and large cell lung cancer. A frequent association. Cancer 60, 903-905. (Pubitemid 17131925)
4. Baldridge, M.T., King, K.Y., and Goodell, M.A. (2011). Inflammatory signals regulate hematopoietic stem cells. Trends Immunol. 32, 57-65.
5. Barber, D.L., Wherry, E.J., Masopust, D., Zhu, B., Allison, J.P., Sharpe, A.H., Freeman, G.J., and Ahmed, R. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687. (Pubitemid 43237609)
6. Bayne, L.J., Beatty, G.L., Jhala, N., Clark, C.E., Rhim, A.D., Stanger, B.Z., and Vonderheide, R.H. (2012). Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21, 822-835.
7. Beyrau, M., Bodkin, J.V., and Nourshargh, S. (2012). Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol 2, 120134.
8. Bhat, N., and Fitzgerald, K.A. (2013). Recognition of Cytosolic DNA by cGAS and other STING-dependent sensors. Eur. J. Immunol.
9. Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A.C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013). Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782-795.
10. Blackburn, S.D., Shin, H., Haining, W.N., Zou, T., Workman, C.J., Polley, A., Betts, M.R., Freeman, G.J., Vignali, D.A., and Wherry, E.J. (2009). Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10, 29-37.
11. Boettcher, S., Ziegler, P., Schmid, M.A., Takizawa, H., van Rooijen, N., Kopf, M., Heikenwalder, M., and Manz, M.G. (2012). Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells. J. Immunol. 188, 5824-5828.
12. Boiko, J.R., and Borghesi, L. (2012). Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine 57, 1-8.
13. Bos, P.D., Plitas, G., Rudra, D., Lee, S.Y., and Rudensky, A.Y. (2013). Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J. Exp. Med. 210, 2435-2466.
14. Burnette, B.C., Liang, H., Lee, Y., Chlewicki, L., Khodarev, N.N., Weichselbaum, R.R., Fu, Y.X., and Auh, S.L. (2011). The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res. 71, 2488-2496.
15. Chou, D.B., Sworder, B., Bouladoux, N., Roy, C.N., Uchida, A.M., Grigg, M., Robey, P.G., and Belkaid, Y. (2012). Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection. J. Leukoc. Biol. 92, 123-131.
16. Crespo, J., Sun, H., Welling, T.H., Tian, Z., and Zou, W. (2013). T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr. Opin. Immunol. 25, 214-221.
17. de Bruin, A.M., Libregts, S.F., Valkhof, M., Boon, L., Touw, I.P., and Nolte, M.A. (2012). IFNγ induces monopoiesis and inhibits neutrophil development during inflammation. Blood 119, 1543-1554.
18. Delano, M.J., Scumpia, P.O., Weinstein, J.S., Coco, D., Nagaraj, S., Kelly-Scumpia, K.M., O'Malley, K.A., Wynn, J.L., Antonenko, S., Al-Quran, S.Z., et al. (2007). MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463-1474. (Pubitemid 46919883)
19. Diamond, M.S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G.P., Archambault, J.M., Lee, H., Arthur, C.D., White, J.M., Kalinke, U., et al. (2011). Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 208, 1989-2003.
20. Dieu-Nosjean, M.C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008). Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J. Clin. Oncol. 26, 4410-4417.
21. Doedens, A.L., Phan, A.T., Stradner, M.H., Fujimoto, J.K., Nguyen, J.V., Yang, E., Johnson, R.S., and Goldrath, A.W. (2013). Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat. Immunol. 14, 1173-1182.
22. Edme, N., Downward, J., Thiery, J.P., and Boyer, B. (2002). Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J. Cell Sci. 115, 2591-2601. (Pubitemid 34778076)
23. Elinav, E., Nowarski, R., Thaiss, C.A., Hu, B., Jin, C., and Flavell, R.A. (2013). Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13, 759-771.
24. Essers, M.A., Offner, S., Blanco-Bose, W.E., Waibler, Z., Kalinke, U., Duchosal, M.A., and Trumpp, A. (2009). IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458, 904-908.
25. Fallarino, F., Orabona, C., Vacca, C., Bianchi, R., Gizzi, S., Asselin-Paturel, C., Fioretti, M.C., Trinchieri, G., Grohmann, U., and Puccetti, P. (2005). Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int. Immunol. 17, 1429-1438. (Pubitemid 41631319)
26. Fox, J.G., Feng, Y., Theve, E.J., Raczynski, A.R., Fiala, J.L., Doernte, A.L., Williams, M., McFaline, J.L., Essigmann, J.M., Schauer, D.B., et al. (2010). Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 59, 88-97.
27. Fuertes, M.B., Woo, S.R., Burnett, B., Fu, Y.X., and Gajewski, T.F. (2013). Type I interferon response and innate immune sensing of cancer. Trends Immunol. 34, 67-73.
28. Gabrilovich, D.I., and Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
29. Gabrilovich, D.I., Bronte, V., Chen, S.H., Colombo, M.P., Ochoa, A., Ostrand-Rosenberg, S., and Schreiber, H. (2007). The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67, 425, author reply 426.
30. Gabrilovich, D.I., Ostrand-Rosenberg, S., and Bronte, V. (2012). Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253-268.
31. Ganal, S.C., Sanos, S.L., Kallfass, C., Oberle, K., Johner, C., Kirschning, C., Lienenklaus, S., Weiss, S., Staeheli, P., Aichele, P., and Diefenbach, A. (2012). Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 37, 171-186.
32. Gattinoni, L., Klebanoff, C.A., and Restifo, N.P. (2012). Paths to stemness: building the ultimate antitumour T cell. Nat. Rev. Cancer 12, 671-684.
33. Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E.E., Trinchieri, G., Caux, C., and Garrone, P. (2005). A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 201, 1435-1446. (Pubitemid 40664087)
34. GeurtsvanKessel, C.H., Willart, M.A., Bergen, I.M., van Rijt, L.S., Muskens, F., Elewaut, D., Osterhaus, A.D., Hendriks, R., Rimmelzwaan, G.F., and Lambrecht, B.N. (2009). Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206, 2339-2349.
35. Goldszmid, R.S., and Trinchieri, G. (2012). The price of immunity. Nat. Immunol. 13, 932-938.
36. Goldszmid, R.S., Caspar, P., Rivollier, A., White, S., Dzutsev, A., Hieny, S., Kelsall, B., Trinchieri, G., and Sher, A. (2012). NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 36, 1047-1059.
37. Gough, D.J., Messina, N.L., Clarke, C.J., Johnstone, R.W., and Levy, D.E. (2012). Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36, 166-174.
38. Grivennikov, S.I., Greten, F.R., and Karin, M. (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.
39. Guiducci, C., Vicari, A.P., Sangaletti, S., Trinchieri, G., and Colombo, M.P. (2005). Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65, 3437-3446. (Pubitemid 40524630)
40. Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
41. Ichinohe, T., Pang, I.K., Kumamoto, Y., Peaper, D.R., Ho, J.H., Murray, T.S., and Iwasaki, A. (2011). Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. USA 108, 5354-5359.
42. Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R.A., Molina, D.A., Salcedo, R., Back, T., Cramer, S., et al. (2013). Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967-970.
43. Iliff, J.J., Wang, M., Liao, Y., Plogg, B.A., Peng, W., Gundersen, G.A., Benveniste, H., Vates, G.E., Deane, R., Goldman, S.A., et al. (2012). A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 4, ra111.
44. Jankovic, D., and Trinchieri, G. (2007). IL-10 or not IL-10: that is the question. Nat. Immunol. 8, 1281-1283. (Pubitemid 350131163)
45. Jobin, C. (2012). Colorectal cancer: CRC - all about microbial products and barrier function? Nat Rev Gastroenterol Hepatol 9, 694-696.
46. Kaufmann, D.E., and Walker, B.D. (2009). PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J. Immunol. 182, 5891-5897.
47. King, K.Y., and Goodell, M.A. (2011). Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 11, 685-692.
48. Koblish, H.K., Hunter, C.A., Wysocka, M., Trinchieri, G., and Lee, W.M. (1998). Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. J. Exp. Med. 188, 1603-1610. (Pubitemid 28516105)
49. Köhler, A., De Filippo, K., Hasenberg, M., van den Brandt, C., Nye, E., Hosking, M.P., Lane, T.E., Männ, L., Ransohoff, R.M., Hauser, A.E., et al. (2011). G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood 117, 4349-4357.
50. Kunisaki, Y., Bruns, I., Scheiermann, C., Ahmed, J., Pinho, S., Zhang, D., Mizoguchi, T., Wei, Q., Lucas, D., Ito, K., et al. (2013). Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502, 637-643.
51. Leach, D.R., Krummel, M.F., and Allison, J.P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736. (Pubitemid 26102823)
52. Link, A., Hardie, D.L., Favre, S., Britschgi, M.R., Adams, D.H., Sixt, M., Cyster, J.G., Buckley, C.D., and Luther, S.A. (2011). Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am. J. Pathol. 178, 1662-1675.
53. Ma, Y., Adjemian, S., Mattarollo, S.R., Yamazaki, T., Aymeric, L., Yang, H., Portela Catani, J.P., Hannani, D., Duret, H., Steegh, K., et al. (2013a). Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity 38, 729-741.
54. Ma, Y., Galluzzi, L., Zitvogel, L., and Kroemer, G. (2013b). Autophagy and cellular immune responses. Immunity 39, 211-227.
55. Martinet, L., Garrido, I., Filleron, T., Le Guellec, S., Bellard, E., Fournie, J.J., Rochaix, P., and Girard, J.P. (2011). Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res. 71, 5678-5687.
56. Matzinger, P. (2002). The danger model: a renewed sense of self. Science 296, 301-305.
57. Matzinger, P., and Kamala, T. (2011). Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 11, 221-230.
58. McGaha, T.L., Huang, L., Lemos, H., Metz, R., Mautino, M., Prendergast, G.C., and Mellor, A.L. (2012). Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol. Rev. 249, 135-157.
59. Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature 454, 428-435.
60. Meulmeester, E., and Ten Dijke, P. (2011). The dynamic roles of TGF-β in cancer. J. Pathol. 223, 205-218.
61. Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M.J., Salcedo, R., Kastenmuller, W., Deming, C., Quinones, M., Koo, L., Conlan, S., et al. (2012). Compartmentalized control of skin immunity by resident commensals. Science 337, 1115-1119.
62. Neyt, K., Perros, F., GeurtsvanKessel, C.H., Hammad, H., and Lambrecht, B.N. (2012). Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol. 33, 297-305.
63. Norde, W.J., Hobo, W., van der Voort, R., and Dolstra, H. (2012). Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention. Blood 120, 728-736.
64. Norris, B.A., Uebelhoer, L.S., Nakaya, H.I., Price, A.A., Grakoui, A., and Pulendran, B. (2013). Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity. Immunity 38, 309-321.
65. Odorizzi, P.M., and Wherry, E.J. (2013). Immunology. An interferon paradox. Science 340, 155-156.
66. Pardoll, D.M. (2012). Immunology beats cancer: a blueprint for successful translation. Nat. Immunol. 13, 1129-1132.
67. Parkin, D.M. (2006). The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118, 3030-3044.
68. Paulos, C.M., Wrzesinski, C., Kaiser, A., Hinrichs, C.S., Chieppa, M., Cassard, L., Palmer, D.C., Boni, A., Muranski, P., Yu, Z., et al. (2007). Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J. Clin. Invest. 117, 2197-2204. (Pubitemid 47219564)
69. Pierce, G.B., and Speers, W.C. (1988). Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res. 48, 1996-2004.
70. Pietras, E.M., Warr, M.R., and Passegué, E. (2011). Cell cycle regulation in hematopoietic stem cells. J. Cell Biol. 195, 709-720.
71. Qin, A., Cai, W., Pan, T., Wu, K., Yang, Q., Wang, N., Liu, Y., Yan, D., Hu, F., Guo, P., et al. (2013). Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J. Virol. 87, 1477-1490.
72. Rangel-Moreno, J., Carragher, D.M., de la Luz Garcia-Hernandez, M., Hwang, J.Y., Kusser, K., Hartson, L., Kolls, J.K., Khader, S.A., and Randall, T.D. (2011). The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12, 639-646.
73. Rao, J.B., Chamberlain, R.S., Bronte, V., Carroll, M.W., Irvine, K.R., Moss, B., Rosenberg, S.A., and Restifo, N.P. (1996). IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J. Immunol. 156, 3357-3365. (Pubitemid 26123552)
74. Rao, V.P., Poutahidis, T., Ge, Z., Nambiar, P.R., Boussahmain, C., Wang, Y.Y., Horwitz, B.H., Fox, J.G., and Erdman, S.E. (2006). Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 66, 7395-7400. (Pubitemid 44289190)
75. Rossi, L., Salvestrini, V., Ferrari, D., Di Virgilio, F., and Lemoli, R.M. (2012). The sixth sense: hematopoietic stem cells detect danger through purinergic signaling. Blood 120, 2365-2375.
76. Round, J.L., Lee, S.M., Li, J., Tran, G., Jabri, B., Chatila, T.A., and Mazmanian, S.K. (2011). The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977.
77. Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.M., Wang, E., Ma, W., Haines, D., O'hUigin, C., et al. (2010). MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207, 1625-1636.
78. Salcedo, R., Cataisson, C., Hasan, U., Yuspa, S.H., and Trinchieri, G. (2013). MyD88 and its divergent toll in carcinogenesis. Trends Immunol. 34, 379-389.
79. Schetter, A.J., Heegaard, N.H., and Harris, C.C. (2010). Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31, 37-49.
80. Schreiber, R.D., Old, L.J., and Smyth, M.J. (2011). Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570.
81. Sears, C.L., and Garrett, W.S. (2014). Microbes, Microbiota, and Colon Cancer. Cell Host Microbe 15, this issue, 317-328.
82. Serbina, N.V., and Pamer, E.G. (2006). Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7, 311-317.
83. Shan, M., Gentile, M., Yeiser, J.R., Walland, A.C., Bornstein, V.U., Chen, K., He, B., Cassis, L., Bigas, A., Cols, M., et al. (2013). Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 342, 447-453.
84. Shields, J.D., Kourtis, I.C., Tomei, A.A., Roberts, J.M., and Swartz, M.A. (2010). Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328, 749-752.
85. Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.H., Yao, J., Blanchard, D., Bais, C., Peale, F.V., van Bruggen, N., et al. (2007). Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450, 825-831. (Pubitemid 350231321)
86. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Glickman, J.N., and Garrett, W.S. (2013). The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573.
87. Stewart, C.A., Metheny, H., Iida, N., Smith, L., Hanson, M., Steinhagen, F., Leighty, R.M., Roers, A., Karp, C.L., Müller, W., and Trinchieri, G. (2013). Interferon- dependent IL-10 production by Tregs limits tumor Th17 inflammation. J. Clin. Invest. 123, 4859-4874.
88. Thaunat, O., Kerjaschki, D., and Nicoletti, A. (2006). Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol. 27, 441-445. (Pubitemid 44354310)
89. Trinchieri, G. (2010). Type I interferon: friend or foe? J. Exp. Med. 207, 2053- 2063.
90. Trinchieri, G. (2012). Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 30, 677-706.
91. van de Pavert, S.A., Olivier, B.J., Goverse, G., Vondenhoff, M.F., Greuter, M., Beke, P., Kusser, K., Höpken, U.E., Lipp, M., Niederreither, K., et al. (2009). Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat. Immunol. 10, 1193-1199.
92. Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D.P., Pfirschke, C., Engblom, C., Pittet, M.J., et al. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976.
93. Voisin, M.B., Buzoni-Gatel, D., Bout, D., and Velge-Roussel, F. (2004). Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis. Infect. Immun. 72, 5487-5492. (Pubitemid 39223441)
94. Wainwright, D.A., Balyasnikova, I.V., Chang, A.L., Ahmed, A.U., Moon, K.S., Auffinger, B., Tobias, A.L., Han, Y., and Lesniak, M.S. (2012). IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin. Cancer Res. 18, 6110-6121.
95. Westbrook, A.M., Wei, B., Hacke, K., Xia, M., Braun, J., and Schiestl, R.H. (2012). The role of tumour necrosis factor-α and tumour necrosis factor receptor signalling in inflammation-associated systemic genotoxicity. Mutagenesis 27, 77-86.
96. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., and Sakaguchi, S. (2008). CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275.
97. Yamamoto, M.L., Maier, I., Dang, A.T., Berry, D., Liu, J., Ruegger, P.M., Yang, J.I., Soto, P.A., Presley, L.L., Reliene, R., et al. (2013). Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity. Cancer Res. 73, 4222-4232.
98. Yan, H.H., Pickup, M., Pang, Y., Gorska, A.E., Li, Z., Chytil, A., Geng, Y., Gray, J.W., Moses, H.L., and Yang, L. (2010). Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 70, 6139-6149.
99. Yu, P., Lee, Y., Liu, W., Chin, R.K., Wang, J., Wang, Y., Schietinger, A., Philip, M., Schreiber, H., and Fu, Y.X. (2004). Priming of naive T cells inside tumors leads to eradication of established tumors. Nat. Immunol. 5, 141-149. (Pubitemid 38208355)
100. Zha, Yy., Blank, C., and Gajewski, T.F. (2004). Negative regulation of T-cell function by PD-1. Crit. Rev. Immunol. 24, 229-237.
101. Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., and Hauser, C.J. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107.